Clinical Trial

Individual Risk Profiles for Adverse Drug Reactions in Geriatric Patients

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
This project will generate a prospective cohort of geriatric patients with polypharmacy which will be characterized for vulnerability profiles of adverse drug reactions.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2022-02-09; most recent amendment 2022-06-17.
Trial Details
NCT Number NCT05247814
Lead Sponsor RWTH Aachen University
Collaborators: B. Braun Foundation
Conditions Polypharmacy, Pharmacogenetics, Pharmacogenomic Testing, Drug-Related Side Effects and Adverse Reactions
Enrollment 2,000 participants
Start Date 2022-07
Primary Completion 2032-02 (estimated)
Study Completion 2032-02 (estimated)
Updated on ClinicalTrials.gov 2022-06-23